Developer docs
API playgroundTry for free, no card

Search company profiles

QAdvis

Full company profile

uuid000kqrf

Namestring
QAdvis
Legal namestring
Aurevia
Websiteurl
qadvis.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

QAdvis, operating commercially as Aurevia, is a European consulting firm headquartered in Uppsala, Sweden, specializing in quality assurance, regulatory affairs, and clinical research services for the pharmaceutical, biotechnology, medical device, and in vitro diagnostic (IVD) industries. The company was originally founded in 2000 as Scandinavian CRO and rebranded to Aurevia in 2015 to reflect an expanded service portfolio beyond traditional CRO work. It now operates two core service lines — Clinical Research CRO Services (clinical operations, project management, pharmacovigilance, medical writing, data management, biostatistics, and adjudication across all trial phases) and Quality Assurance & Regulatory Affairs (QARA) Services (regulatory strategy, market registrations in EU/UK/US, technical documentation, clinical/performance evaluation, vigilance, and post-market surveillance) — supported by the Aurevia Academy training sub-brand and the Lean Entries e-tool.

The business operates on a professional services model, with revenue generated through project-based, quote-priced consulting engagements, supplemented by training course fees and e-tool licensing. Go-to-market is sales-led and consultative, targeting enterprise pharma/biotech clients as well as mid-market medical device and IVD manufacturers, with additional work for academic medical centers. The customer base spans global pharma majors (Novartis, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Shionogi), Nordic and European mid-market medtech firms (iCare, Reagena, Mylab, Vivago, Nightingale Health, NE Device SW, Forsante), and a long tail of smaller biotech and academic clients, totaling roughly 200 annual clients and 1,000+ projects over the firm's 25-year history.

Aurevia is a privately held, management/founder-controlled firm with no disclosed external funding, no parent company, and no subsidiaries. The company is differentiated primarily by deep regulatory expertise (including offering regulated roles such as European Authorised Representative, UK Responsible Person, and Person Responsible for Regulatory Compliance), and by an experienced bench of 100+ quality, regulatory, and clinical research professionals. Strategic positioning has shifted modestly toward productization via Aurevia Academy and Lean Entries, and toward ecosystem visibility through a 2027 partnership with RAPS for the Medtech Compliance Forum.

Short descriptiontext

Aurevia is a Swedish consulting firm providing quality assurance, regulatory affairs, and clinical research services to pharmaceutical, biotech, medical device, and IVD companies across Europe. It operates through CRO, QARA, and Aurevia Academy training service lines, with 100+ professionals serving roughly 200 clients annually.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKista, Sweden
HQ citystring
Kista
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device regulatory consulting, clinical research services, quality management consulting, pharmaceutical CRO services, medtech compliance training
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Regulatory Affairs and Clinical Research Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1CRO Clinical Research Services
TypeProfessional Services
Description

Full-service CRO clinical trial services for pharma and biotech covering all phases of clinical development, including clinical operations, project management, pharmacovigilance, medical writing, data management, and biostatistics.

aurevia.com
2Quality Assurance and Regulatory Affairs Consulting
TypeProfessional Services
Description

Quality assurance and regulatory affairs services covering the lifecycle of medical devices and IVD devices, including regulatory strategy, market registrations, technical documentation, clinical evaluation, and QMS services.

aurevia.com
3Training Services (Aurevia Academy)
TypeProfessional Services
Description

Professional training services within quality assurance, regulatory affairs, and clinical research including seminars, online courses, and tailored training programs.

aurevia.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Aurevia Academy
Description

Professional training services within quality assurance, regulatory affairs, and clinical research including seminars, online courses, and tailored training programs.

aurevia.com
+1 more record
Core offering1 text field

Aurevia provides Medtech quality and system management, risk management, regulatory affairs, compliance, training, interim management, and clinical research CRO services. Its core offering consists of two integrated service lines: Clinical Research CRO Services (clinical operations, project management, pharmacovigilance, medical writing, data management, biostatistics across all phases) and Quality Assurance & Regulatory Affairs (QARA) Services covering the entire lifecycle of medical devices and IVD devices (regulatory strategy, market registrations, technical documentation, clinical evaluation, post-market surveillance). These are complemented by the Aurevia Academy training program and the Lean Entries e-tool for regulatory strategy.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Aurevia is a consulting services firm offering a portfolio of interconnected professional services for the healthcare, pharmaceutical, and medical technology sectors. The core offering consists of two main service lines: Clinical Research CRO Services (covering clinical operations, project management, pharmacovigilance, data management, biostatistics, and medical writing) and Quality Assurance & Regulatory Affairs (QARA) Services (covering regulatory strategy, market registrations, technical documentation, clinical evaluation, and post-market surveillance). Supporting these core services are Aurevia Academy (professional training including seminars, online courses, and tailored programs) and Lean Entries (an e-tool for converting regulatory requirements into actionable strategies). The company also provides specialized services in pharmacovigilance, medical device software consulting, and European/UK regulatory representation.

Product and service4 records
1Clinical Research CRO Services
CategoryClinical Research CRO Services
Description

Full-service contract research organization (CRO) supporting pharmaceutical, biotechnology, and medical device/IVD sponsors plus academia to design and conduct clinical research across all phases, including clinical operations, clinical project management, clinical adjudication, pharmacovigilance, medical writing, data management, biostatistics, equipment rental, investigator-initiated trials, and outsourcing solutions.

2Quality Assurance & Regulatory Affairs (QARA) Services
CategoryQuality Assurance and Regulatory Affairs Consulting
Description

Quality assurance and regulatory affairs consulting covering the full lifecycle of medical devices and IVD medical devices, including regulatory strategy, market registrations, European Authorised Representative (EAR), UK Responsible Person (UKRP), digital health and cybersecurity, technical documentation, clinical evaluation, performance evaluation, biological evaluation, risk management, usability engineering, due diligence, PRRC, QMS services, eQMS solutions, US FDA QMSR, medical device development environments, auditing services, and post-market surveillance.

3Aurevia Academy
CategoryProfessional Training and Education
Description

Professional training services within quality assurance, regulatory affairs, and clinical research including standard seminars, online courses, and tailored corporate training programs for pharma, biotech, and medtech organizations, accessible via the Aurevia Academy learning portal.

4Lean Entries
CategoryRegulatory Strategy Software/Tool
Description

E-tool that helps turn complex regulatory requirements into actionable strategies for medtech and life sciences clients.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2027-02-11
Description

Partnership with RAPS to strengthen medtech regulatory compliance expertise. Co-organizing Medtech Compliance Forum as part of Labquality Days: 11-12 February 2027. This partnership combines Aurevia's expertise in medical device regulatory affairs with RAPS' professional society network.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global regulatory, compliance, and pharmacovigilance consulting firm serving pharma and medtech across the product lifecycle — directly comparable to Aurevia's CRO plus QARA service mix and enterprise customer base.

TypeDirect peer
Description

Regulatory affairs and pharmacovigilance consulting/CRO serving pharma and medtech globally; closely comparable in regulated services portfolio to Aurevia, with similar EU MDR/IVDR positioning.

TypeDirect peer
Description

Benelux-headquartered consulting and CRO group focused on quality, regulatory, and clinical services for medtech, pharma, and biotech — directly mirrors Aurevia's Nordic-focused multi-disciplinary consulting model.

TypeDirect peer
Description

Medtech regulatory and quality consulting firm specializing in EU MDR/IVDR, FDA, and global submissions, plus clinical and post-market services — a tight direct peer on Aurevia's medtech QARA offering.

TypeDirect peer
Description

Dutch medtech-focused regulatory, quality, and clinical consulting firm with deep EU MDR expertise — comparable niche specialization and customer mix to Aurevia's medtech practice.

6TFS International
TypeDirect peer
Description

European-headquartered CRO delivering clinical, regulatory, and pharmacovigilance services to pharma and medtech companies — closely aligned with Aurevia's clinical research CRO offering and Nordic roots.

TypeBroad incumbent
Description

One of the world's largest CROs providing full-service clinical development, regulatory, and consulting; represents the global incumbent against which mid-tier European CROs like Aurevia compete for enterprise mandates.

TypeBroad incumbent
Description

Major global CRO offering clinical, regulatory, and real-world evidence services across pharma and medtech — sets the competitive ceiling on enterprise deals that Aurevia's pharma/biotech clients also run.

TypeBroad incumbent
Description

Global contract research organization spanning discovery, safety, and clinical development — a broad incumbent comparable to Aurevia on the preclinical/clinical research side.

10TÜV SÜD
TypeBroad incumbent
Description

Global testing, inspection, certification, and notified body organization providing medtech regulatory and quality services including ISO 13485 and MDR — a broader incumbent adjacent to Aurevia's regulatory/QA service line.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers22 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

QAdvis

Regulatory Affairs and Clinical Research Consultingqadvis.com

Aurevia is a Swedish consulting firm providing quality assurance, regulatory affairs, and clinical research services to pharmaceutical, biotech, medical device, and IVD companies across Europe. It operates through CRO, QARA, and Aurevia Academy training service lines, with 100+ professionals serving roughly 200 clients annually.

What QAdvis does

QAdvis, operating commercially as Aurevia, is a European consulting firm headquartered in Uppsala, Sweden, specializing in quality assurance, regulatory affairs, and clinical research services for the pharmaceutical, biotechnology, medical device, and in vitro diagnostic (IVD) industries. The company was originally founded in 2000 as Scandinavian CRO and rebranded to Aurevia in 2015 to reflect an expanded service portfolio beyond traditional CRO work. It now operates two core service lines — Clinical Research CRO Services (clinical operations, project management, pharmacovigilance, medical writing, data management, biostatistics, and adjudication across all trial phases) and Quality Assurance & Regulatory Affairs (QARA) Services (regulatory strategy, market registrations in EU/UK/US, technical documentation, clinical/performance evaluation, vigilance, and post-market surveillance) — supported by the Aurevia Academy training sub-brand and the Lean Entries e-tool.

The business operates on a professional services model, with revenue generated through project-based, quote-priced consulting engagements, supplemented by training course fees and e-tool licensing. Go-to-market is sales-led and consultative, targeting enterprise pharma/biotech clients as well as mid-market medical device and IVD manufacturers, with additional work for academic medical centers. The customer base spans global pharma majors (Novartis, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Shionogi), Nordic and European mid-market medtech firms (iCare, Reagena, Mylab, Vivago, Nightingale Health, NE Device SW, Forsante), and a long tail of smaller biotech and academic clients, totaling roughly 200 annual clients and 1,000+ projects over the firm's 25-year history.

Aurevia is a privately held, management/founder-controlled firm with no disclosed external funding, no parent company, and no subsidiaries. The company is differentiated primarily by deep regulatory expertise (including offering regulated roles such as European Authorised Representative, UK Responsible Person, and Person Responsible for Regulatory Compliance), and by an experienced bench of 100+ quality, regulatory, and clinical research professionals. Strategic positioning has shifted modestly toward productization via Aurevia Academy and Lean Entries, and toward ecosystem visibility through a 2027 partnership with RAPS for the Medtech Compliance Forum.

QAdvis firmographics

Firmographics
Name
QAdvis
Legal name
Aurevia
Website
https://qadvis.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Aurevia is a Swedish consulting firm providing quality assurance, regulatory affairs, and clinical research services to pharmaceutical, biotech, medical device, and IVD companies across Europe. It operates through CRO, QARA, and Aurevia Academy training service lines, with 100+ professionals serving roughly 200 clients annually.
Ownership category
akta.pro rank

QAdvis industry classification

Industry
Product category
Regulatory Affairs and Clinical Research Consulting
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Medical device regulatory consulting
  • Clinical research services
  • Quality management consulting
  • Pharmaceutical CRO services
  • Medtech compliance training

Where QAdvis is headquartered

Location

Headquarters

HQ city
Kista
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

QAdvis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. CRO Clinical Research Services: Full-service CRO clinical trial services for pharma and biotech covering all phases of clinical development, including clinical operations, project management, pharmacovigilance, medical writing, data management, and biostatistics.
  2. Quality Assurance and Regulatory Affairs Consulting: Quality assurance and regulatory affairs services covering the lifecycle of medical devices and IVD devices, including regulatory strategy, market registrations, technical documentation, clinical evaluation, and QMS services.
  3. Training Services (Aurevia Academy): Professional training services within quality assurance, regulatory affairs, and clinical research including seminars, online courses, and tailored training programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

QAdvis product offering

Product offering

Core offering

Aurevia provides Medtech quality and system management, risk management, regulatory affairs, compliance, training, interim management, and clinical research CRO services. Its core offering consists of two integrated service lines: Clinical Research CRO Services (clinical operations, project management, pharmacovigilance, medical writing, data management, biostatistics across all phases) and Quality Assurance & Regulatory Affairs (QARA) Services covering the entire lifecycle of medical devices and IVD devices (regulatory strategy, market registrations, technical documentation, clinical evaluation, post-market surveillance). These are complemented by the Aurevia Academy training program and the Lean Entries e-tool for regulatory strategy.

Product overview

Aurevia is a consulting services firm offering a portfolio of interconnected professional services for the healthcare, pharmaceutical, and medical technology sectors. The core offering consists of two main service lines: Clinical Research CRO Services (covering clinical operations, project management, pharmacovigilance, data management, biostatistics, and medical writing) and Quality Assurance & Regulatory Affairs (QARA) Services (covering regulatory strategy, market registrations, technical documentation, clinical evaluation, and post-market surveillance). Supporting these core services are Aurevia Academy (professional training including seminars, online courses, and tailored programs) and Lean Entries (an e-tool for converting regulatory requirements into actionable strategies). The company also provides specialized services in pharmacovigilance, medical device software consulting, and European/UK regulatory representation.

Differentiator

Problem solved

Functional benefit

Brands

  • Aurevia Academy: Professional training services within quality assurance, regulatory affairs, and clinical research including seminars, online courses, and tailored training programs.
  • Lean Entries

Products and services

  • Clinical Research CRO Services Full-service contract research organization (CRO) supporting pharmaceutical, biotechnology, and medical device/IVD sponsors plus academia to design and conduct clinical research across all phases, including clinical operations, clinical project management, clinical adjudication, pharmacovigilance, medical writing, data management, biostatistics, equipment rental, investigator-initiated trials, and outsourcing solutions.
  • Quality Assurance & Regulatory Affairs (QARA) Services Quality assurance and regulatory affairs consulting covering the full lifecycle of medical devices and IVD medical devices, including regulatory strategy, market registrations, European Authorised Representative (EAR), UK Responsible Person (UKRP), digital health and cybersecurity, technical documentation, clinical evaluation, performance evaluation, biological evaluation, risk management, usability engineering, due diligence, PRRC, QMS services, eQMS solutions, US FDA QMSR, medical device development environments, auditing services, and post-market surveillance.
  • Aurevia Academy Professional training services within quality assurance, regulatory affairs, and clinical research including standard seminars, online courses, and tailored corporate training programs for pharma, biotech, and medtech organizations, accessible via the Aurevia Academy learning portal.
  • Lean Entries E-tool that helps turn complex regulatory requirements into actionable strategies for medtech and life sciences clients.

Companies that use QAdvis

Customer profile

Named customers22 records

Segments4 records

Ideal customer profiles5 records

QAdvis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

QAdvis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • RAPS (Regulatory Affairs Professionals Society)coreStrategic or Co-development Partner · 11 February 2027Partnership with RAPS to strengthen medtech regulatory compliance expertise. Co-organizing Medtech Compliance Forum as part of Labquality Days: 11-12 February 2027. This partnership combines Aurevia's expertise in medical device regulatory affairs with RAPS' professional society network.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

QAdvis competitors and assessment

Company assessment

Direct peers

  • ProPharma Group: Global regulatory, compliance, and pharmacovigilance consulting firm serving pharma and medtech across the product lifecycle — directly comparable to Aurevia's CRO plus QARA service mix and enterprise customer base.
  • PharmaLex: Regulatory affairs and pharmacovigilance consulting/CRO serving pharma and medtech globally; closely comparable in regulated services portfolio to Aurevia, with similar EU MDR/IVDR positioning.
  • QbD Group: Benelux-headquartered consulting and CRO group focused on quality, regulatory, and clinical services for medtech, pharma, and biotech — directly mirrors Aurevia's Nordic-focused multi-disciplinary consulting model.
  • RQM+: Medtech regulatory and quality consulting firm specializing in EU MDR/IVDR, FDA, and global submissions, plus clinical and post-market services — a tight direct peer on Aurevia's medtech QARA offering.
  • Qserve Group: Dutch medtech-focused regulatory, quality, and clinical consulting firm with deep EU MDR expertise — comparable niche specialization and customer mix to Aurevia's medtech practice.
  • TFS International: European-headquartered CRO delivering clinical, regulatory, and pharmacovigilance services to pharma and medtech companies — closely aligned with Aurevia's clinical research CRO offering and Nordic roots.

Broad incumbents

  • ICON plc: One of the world's largest CROs providing full-service clinical development, regulatory, and consulting; represents the global incumbent against which mid-tier European CROs like Aurevia compete for enterprise mandates.
  • Parexel International: Major global CRO offering clinical, regulatory, and real-world evidence services across pharma and medtech — sets the competitive ceiling on enterprise deals that Aurevia's pharma/biotech clients also run.
  • Charles River Laboratories: Global contract research organization spanning discovery, safety, and clinical development — a broad incumbent comparable to Aurevia on the preclinical/clinical research side.
  • TÜV SÜD: Global testing, inspection, certification, and notified body organization providing medtech regulatory and quality services including ISO 13485 and MDR — a broader incumbent adjacent to Aurevia's regulatory/QA service line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

QAdvis social profiles

Digital presence

QAdvis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

QAdvis leadership team

Management profile

Number of profiles

Profiles3 records

QAdvis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

QAdvis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QAdvis

What does QAdvis do?

Aurevia provides Medtech quality and system management, risk management, regulatory affairs, compliance, training, interim management, and clinical research CRO services. Its core offering consists of two integrated service lines: Clinical Research CRO Services (clinical operations, project management, pharmacovigilance, medical writing, data management, biostatistics across all phases) and Quality Assurance & Regulatory Affairs (QARA) Services covering the entire lifecycle of medical devices and IVD devices (regulatory strategy, market registrations, technical documentation, clinical evaluation, post-market surveillance). These are complemented by the Aurevia Academy training program and the Lean Entries e-tool for regulatory strategy.

Is QAdvis a public or private company?

QAdvis is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was QAdvis founded?

QAdvis was founded in 2000. It employs 11 to 50 people.

Where is QAdvis based?

QAdvis is headquartered in Kista, Sweden, in the Europe region.

How does QAdvis make money?

Three revenue lines are on record. CRO Clinical Research Services are the primary driver. The others are quality Assurance and Regulatory Affairs Consulting and training Services (Aurevia Academy).

Who are QAdvis's main competitors?

Direct peers on record are ProPharma Group, PharmaLex, QbD Group, RQM+, Qserve Group and TFS International. Broad incumbents are ICON plc, Parexel International, Charles River Laboratories and TÜV SÜD.

Does QAdvis have an API?

No public API is recorded for QAdvis.

What industry is QAdvis in?

QAdvis's product category is Regulatory Affairs and Clinical Research Consulting. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales